Novel therapy for male hypogonadism

R Carrasquillo, K Chu, R Ramasamy - Current urology reports, 2018 - Springer
Abstract Purpose of Review Hypogonadism and the treatment of low testosterone is
increasingly a subject of medical inquiry and controversy. The few treatments that are FDA …

Emerging drugs for hypogonadism

D Edelstein, A Dobs, S Basaria - Expert opinion on emerging drugs, 2006 - Taylor & Francis
Male hypogonadism is a common endocrine problem that affects men of all ages. Recently,
there has been a surge in testosterone use among middle-aged and older men who in the …

[HTML][HTML] Treatment of hypogonadism: current and future therapies

A Thirumalai, KE Berkseth, JK Amory - F1000Research, 2017 - ncbi.nlm.nih.gov
The treatment of hypogonadism in men is of great interest to both patients and providers.
There are a number of testosterone formulations currently available and several additional …

An update on male hypogonadism therapy

P Surampudi, RS Swerdloff, C Wang - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Men who have symptoms associated with persistently low serum total
testosterone level should be assessed for testosterone replacement therapy. Areas covered …

The latest options and future agents for treating male hypogonadism

D Edelstein, M Sivanandy, S Shahani… - Expert opinion on …, 2007 - Taylor & Francis
Exogenous testosterone has long been used in medicine as a pharmaceutical agent. Its use
in hypogonadism is well characterized and its development as a drug has undergone …

Male hypogonadism: an update on diagnosis and treatment

E Darby, BD Anawalt - Treatments in endocrinology, 2005 - Springer
Male hypogonadism is one of the most common endocrinologic syndromes. The diagnosis
is based on clinical signs and symptoms plus laboratory confirmation via the measurement …

Male hypogonadism: therapeutic choices and pharmacological management.

S La Vignera, G Izzo, GP Emerenziani… - Minerva …, 2020 - europepmc.org
Male hypogonadism, defined as an inadequate testosterone production, recognizes a
testicular (primary hypogonadism) or a hypothalamic-pituitary dysfunction (central …

[HTML][HTML] Off label therapies for testosterone replacement

L DiGiorgio, H Sadeghi-Nejad - Translational Andrology and …, 2016 - ncbi.nlm.nih.gov
The incidence of hypogonadism has been steadily increasing over the last few years.
Exogenous testosterone has been the standard treatment for hypogonadal men, but is …

[HTML][HTML] Non-testosterone management of male hypogonadism: an examination of the existing literature

SC Krzastek, RP Smith - Translational andrology and urology, 2020 - ncbi.nlm.nih.gov
Testosterone deficiency is defined as a total testosterone level< 300 ng/dL confirmed on two
early morning lab draws. Testosterone therapy has historically been offered to men with …

Novel androgen therapies including selective androgen receptor modulators

J Kang, R Chen, T Tharakan, S Minhas - Best Practice & Research Clinical …, 2022 - Elsevier
Male hypogonadism is associated with reduced quality of life and the development of co-
morbidities including obesity, diabetes mellitus, and dyslipidaemia. The mainstay of …